Wenwei Yin Selected Research

entecavir

2/2014

Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenwei Yin Research Topics

Disease

6	Infections 01/2020 - 02/2013
3	Chronic Hepatitis B 09/2018 - 04/2014
3	Hepatitis B 10/2015 - 02/2013
1	Hepatitis 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Cerebral Infarction 07/2018
1	Inflammation (Inflammations) 07/2018
1	Edema (Dropsy) 07/2015
1	Hepatocellular Carcinoma (Hepatoma) 07/2015
1	Ascites 07/2015
1	Fibrosis (Cirrhosis) 02/2014

Drug/Important Bio-Agent (IBA)

3	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2018 - 02/2013
1	GalactosamineIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	NucleosidesIBA 09/2018
1	Proteins (Proteins, Gene)FDA Link 07/2018
1	MicroRNAs (MicroRNA)IBA 07/2018
1	Poly I-CIBA 01/2017
1	InterferonsIBA 01/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	Interleukin-10 (Interleukin 10)IBA 10/2015
1	Antiviral Agents (Antivirals)IBA 10/2015
1	Branched-Chain Amino AcidsIBA 07/2015
1	Serum AlbuminIBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2014
1	entecavir FDA Link 02/2014
1	lipoarabinomannan (LAM)IBA 02/2014
1	adefovirIBA 02/2014
1	adefovir dipivoxil (Hepsera)FDA Link 02/2014
1	Lamivudine (Epivir)FDA Link 02/2014
1	NK Cell Lectin-Like Receptor Subfamily CIBA 02/2013
1	Indicators and Reagents (Reagents)IBA 02/2013
1	LigandsIBA 02/2013
1	Blocking AntibodiesIBA 02/2013
1	Natural Killer Cell ReceptorsIBA 02/2013

Therapy/Procedure

2	Therapeutics 09/2018 - 01/2016
1	Immunotherapy 01/2020